Edition:
United Kingdom

People: Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.64USD
19 Aug 2019
Change (% chg)

$-0.02 (-3.48%)
Prev Close
$0.66
Open
$0.65
Day's High
$0.66
Day's Low
$0.64
Volume
15,119
Avg. Vol
33,759
52-wk High
$1.32
52-wk Low
$0.55

Cloyd, Mary 

Ms. Mary Ann Cloyd is Independent Director of the company. She was a Senior Partner with PricewaterhouseCoopers (PwC) with responsibility for leading PwC's Center for Board Governance at the time of her retirement in 2015. Ms. Cloyd has over 39 years of public accounting experience serving multinational corporate clients in a variety of industries including biotechnology and pharmaceuticals. Ms. Cloyd has served on both PwC's Global and US Boards, where she chaired the Risk Management, Ethics & Compliance Committee and the Partner Admissions Committee on the US Board. On the Global Board, she served on the Risk and Operations Committee and the Clients Committee. Ms. Cloyd is on the Board of Trustees of the PricewaterhouseCoopers Charitable Foundation, Inc. and a past President of the Foundation, and she is Chair of the UCLA Iris Cantor Women's Center Advisory Board. Ms. Cloyd graduated Summa Cum Laude from Baylor University with a Bachelor of Business Administration.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --